COO Cooper Companies Inc.

CooperCompanies to Participate in Upcoming Investor Conferences

CooperCompanies to Participate in Upcoming Investor Conferences

SAN RAMON, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced its participation in the following upcoming investor conferences:

2024 Wells Fargo Healthcare Conference

Wednesday, September 4, 2024, at 3:45 pm ET

Al White, President & Chief Executive Officer, will represent the Company in a fireside chat

Morgan Stanley Annual Global Healthcare Conference

Thursday, September 5, 2024, at 1:50 pm ET

Al White, President & Chief Executive Officer, will represent the Company in a fireside chat

A webcast of each session will be available to investors and other interested parties by accessing the CooperCompanies’ website at .

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit .

Contact:

Kim Duncan

Vice President, Investor Relations and Risk Management

925-460-3663



EN
08/08/2024

Underlying

COOCooper Companies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cooper Companies Inc.

 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Release Date for Fourth Quarter and Full Yea...

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2024 SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 2026064. A simultaneous audio webcast and subsequent replay can be accessed at . About CooperCo...

November 12, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Recognized as a Best Workplace for Innovators

CooperCompanies Recognized as a Best Workplace for Innovators Leading global medical device company recognized for culture that drives innovation for customers and patients SAN RAMON, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) --  CooperCompanies (Nasdaq: COO) announced today that the company has been recognized as a Best Workplace for Innovators by Fast Company—a leading business media brand with an editorial focus on innovation—for creating a culture of employee development and belonging that inspires innovation and the development of new products and advocacy initiatives that aim to imp...

September 10, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Third Quarter 2024 Results

CooperCompanies Announces Third Quarter 2024 Results SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. Revenue increased 8% year-over-year to $1,002.8 million. CooperVision (CVI) revenue up 7% to $675.6 million, and CooperSurgical (CSI) revenue up 9% to $327.2 million.GAAP diluted earnings per share (EPS) of $0.52, up $0.09 or 22% from last year's third quarter.Non-GAAP diluted EPS of $0.96, up $0.12 or 14% from last year's third q...

August 28, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies to Participate in Upcoming Investor Conferences

CooperCompanies to Participate in Upcoming Investor Conferences SAN RAMON, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced its participation in the following upcoming investor conferences: 2024 Wells Fargo Healthcare ConferenceWednesday, September 4, 2024, at 3:45 pm ETAl White, President & Chief Executive Officer, will represent the Company in a fireside chat Morgan Stanley Annual Global Healthcare Conference Thursday, September 5, 2024, at 1:50 pm ETAl White, President & Chief Executive Officer, ...

August 8, 2024 1 EN
 PRESS RELEASE
Free
COO Cooper Companie...

CooperCompanies Announces Release Date for Third Quarter 2024

CooperCompanies Announces Release Date for Third Quarter 2024 SAN RAMON, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report third quarter 2024 financial results on Wednesday, August 28, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7528310. A simultaneous audio webcast and subsequent replay can be accessed at . About CooperCompaniesCooperCompanies (Nasdaq...

August 6, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch